Trials / Completed
CompletedNCT01408511
HPA Axis Study in Adults
A Multicenter, Open Label Study to Evaluate the Adrenal Suppression Potential of Mapracorat 0.1% Ointment in Adults With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A multicenter, open-label study to evaluate the adrenal suppression potential of Mapracorat 0.1% ointment in adults with atopic dermatitis.
Detailed description
Assessment of safety, efficacy, pharmacokinetics and adrenal suppression potential of Mapracorat 0.1% ointment in adults with atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mapracorat | Application of the investigational product on the affected skin areas |
Timeline
- Start date
- 2011-07-19
- Primary completion
- 2011-12-15
- Completion
- 2011-12-21
- First posted
- 2011-08-03
- Last updated
- 2023-10-31
Locations
3 sites across 1 country: South Africa
Source: ClinicalTrials.gov record NCT01408511. Inclusion in this directory is not an endorsement.